Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weitz

Showing results (611-620 of 3,839) with videos related to

Pageof 384
Sort By:
Current Pharmaceutical Design|November 25, 2005
Pharmacology and clinical potential of direct thrombin inhibitorsLori-Ann Linkins, Jeffrey I Weitz
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2018
Advances in Antithrombotic TherapyJeffrey I Weitz, Noel C Chan
Arteriosclerosis, Thrombosis, and Vascular Biology|December 23, 2017
2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis: Factor XI as a Target for New AnticoagulantsJeffrey I Weitz, James C Fredenburgh
Circulation Research|February 1, 2019
Antithrombotic AgentsNoel C Chan, Jeffrey I Weitz
Annals of Internal Medicine|July 18, 2017
Web Exclusives. Annals Consult Guys - Let Me Out of Here! How Long to Remain Hospitalized After an MIGeno J Merli, Howard H Weitz
Annals of Internal Medicine|July 17, 2023
Web Exclusive. Annals Consult Guys - Can You Stop Heart Failure Medications if the Ejection Fraction Recovers?Howard H Weitz, Geno J Merli
Arteriosclerosis, Thrombosis, and Vascular Biology|July 5, 2003
Emerging anticoagulant drugsShannon M Bates, Jeffrey I Weitz
Harefuah|April 17, 2001
[Specific learning and cognitive deficits in neurofibromatosis type 1]M Mahajnah, S Zimmerman, R Weitz
Circulation|November 25, 2016
Response by Weitz and Eikelboom to Letter Regarding Article, "Urgent Need to Measure Effects of Direct Oral Anticoagulants"Jeffrey I Weitz, John W Eikelboom
Nature Communications|February 15, 2014
Veselago lensing with ultracold atoms in an optical latticeMartin Leder, Christopher Grossert, Martin Weitz
Pageof 384

Showing results (611-620 of 3,839) with videos related to

Sort By:
Pageof 384
Current Pharmaceutical Design|November 25, 2005
Pharmacology and clinical potential of direct thrombin inhibitorsLori-Ann Linkins, Jeffrey I Weitz
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2018
Advances in Antithrombotic TherapyJeffrey I Weitz, Noel C Chan
Arteriosclerosis, Thrombosis, and Vascular Biology|December 23, 2017
2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis: Factor XI as a Target for New AnticoagulantsJeffrey I Weitz, James C Fredenburgh
Circulation Research|February 1, 2019
Antithrombotic AgentsNoel C Chan, Jeffrey I Weitz
Annals of Internal Medicine|July 18, 2017
Web Exclusives. Annals Consult Guys - Let Me Out of Here! How Long to Remain Hospitalized After an MIGeno J Merli, Howard H Weitz
Annals of Internal Medicine|July 17, 2023
Web Exclusive. Annals Consult Guys - Can You Stop Heart Failure Medications if the Ejection Fraction Recovers?Howard H Weitz, Geno J Merli
Arteriosclerosis, Thrombosis, and Vascular Biology|July 5, 2003
Emerging anticoagulant drugsShannon M Bates, Jeffrey I Weitz
Harefuah|April 17, 2001
[Specific learning and cognitive deficits in neurofibromatosis type 1]M Mahajnah, S Zimmerman, R Weitz
Circulation|November 25, 2016
Response by Weitz and Eikelboom to Letter Regarding Article, "Urgent Need to Measure Effects of Direct Oral Anticoagulants"Jeffrey I Weitz, John W Eikelboom
Nature Communications|February 15, 2014
Veselago lensing with ultracold atoms in an optical latticeMartin Leder, Christopher Grossert, Martin Weitz
Pageof 384